The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2021 4

United States 2

Journal Article 4
Presentation 1

Conference Publications 1

1 - 5 of 5 Results

Refine Results

Refine Results:

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

CITE Title : Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons Personal Author(s) : Shimabukuro, Tom T.;Kim, Shin Y.;Myers, Tanya R.;Moro, Pedro L.;Oduyebo, Titilope;Panagiotakopoulos, Lakshmi;Marquez, Paige L.;Olson, Christine K.;Liu, Ruiling;Chang, Karen T.;Ellington, Sascha R.;Burkel, Veronica K.;Smoots, Ashley N.;Green, Caitlin J.;Licata, Charles;Zhang, Bicheng C.;Alimchandani, Meghna;Mba-Jonas, Adamma;Martin, Stacey W.;Gee, Julianne M.;Meaney-Delman, Dana M.; Published Date : June 17 2021 Source : N Engl J Med. 2021; URL : https://stacks.cdc.gov/view/cdc/106333 Shimabukuro, Tom T. et al. (2021). Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Shimabukuro, Tom T. et al. "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons" (2021) Shimabukuro, Tom T. et al. "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons" , 2021 Export RIS Citation Information.

:

Shimabukuro, Tom T. ;

Kim, Shin Y.

June 17 2021 | N Engl J Med. 2021;

:

BackgroundMany pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are lim...
Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine : Vaccine Adverse Event Reporting System (VAERS)

CITE Title : Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine : Vaccine Adverse Event Reporting System (VAERS) Personal Author(s) : Alimchandani, Meghna Corporate Authors(s) : United States. Food and Drug Administration. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2021 July 22: Atlanta, GA) Published Date : 07/22/2021 Series : ACIP meeting COVID-19 Vaccines URL : https://stacks.cdc.gov/view/cdc/108880 Alimchandani, Meghna (2021). Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine : Vaccine Adverse Event Reporting System (VAERS). 202109(100102). Alimchandani, Meghna "Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine : Vaccine Adverse Event Reporting System (VAERS)" 202109, no. 100102 (2021) Alimchandani, Meghna "Guillain-Barré Syndrome (GBS) after Janssen COVID-19 vaccine : Vaccine Adverse Event Reporting System (VAERS)" vol. 202109, no. 100102, 2021 Export RIS Citation Information.

:

Alimchandani, Meghna

07/22/2021 | ACIP meeting COVID-19 Vaccines

:

02-COVID-Alimchandani-508.pdf
COVID-19 Vaccine Safety First Year Findings in Adolescents

CITE Title : COVID-19 Vaccine Safety First Year Findings in Adolescents Personal Author(s) : Hesse, Elisabeth M.;Hause, Anne;Myers, Tanya;Su, John R.;Marquez, Paige;Zhang, Bicheng;Cortese, Margaret;Allen, Andrea Thames;Curtis, Christine R.;Maloney, Susan A.;Thompson, Deborah;Nair, Narayan;Alimchandani, Meghna;Niu, Manette;Gee, Julianne;Shay, David K.;Shimabukuro, Tom T.; Published Date : 5 01 2023;5-01-; Source : Pediatrics. 151(5) URL : https://stacks.cdc.gov/view/cdc/129865 Hesse, Elisabeth M. et al. (2023). COVID-19 Vaccine Safety First Year Findings in Adolescents. 151(5). Hesse, Elisabeth M. et al. "COVID-19 Vaccine Safety First Year Findings in Adolescents" 151, no. 5 (2023) Hesse, Elisabeth M. et al. "COVID-19 Vaccine Safety First Year Findings in Adolescents" vol. 151, no. 5, 2023 Export RIS Citation Information.

:

Hesse, Elisabeth M. ;

Hause, Anne

5 01 2023 | Pediatrics. 151(5)

:

Background/Objectives:The Food and Drug Administration (FDA) expanded Emergency Use Authorization (EUA) for use of Pfizer-BioNTech (BNT-162b2) COVID-1...
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

CITE Title : Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021 Personal Author(s) : Rosenblum, Hannah G.;Hadler, Stephen C.;Moulia, Danielle;Shimabukuro, Tom T.;Su, John R.;Tepper, Naomi K.;Ess, Kevin C.;Woo, Emily Jane;Mba-Jonas, Adamma;Alimchandani, Meghna;Nair, Narayan;Klein, Nicola P.;Hanson, Kayla E.;Markowitz, Lauri E.;Wharton, Melinda;McNally, Veronica V.;Romero, José R.;Talbot, H. Keipp;Lee, Grace M.;Daley, Matthew F.;Mbaeyi, Sarah A.;Oliver, Sara E.; Published Date : 8 13 2021 Pages in Document : 6 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 70(32):1094-1099 DOI : http://dx.doi.org/10.15585/mmwr.mm7032e4 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Rosenblum, Hannah G. et al. (2021). Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021. 70(32). http://dx.doi.org/10.15585/mmwr.mm7032e4 Rosenblum, Hannah G. et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021" 70, no. 32 (2021), http://dx.doi.org/10.15585/mmwr.mm7032e4 Rosenblum, Hannah G. et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021" vol. 70, no. 32, 2021, http://dx.doi.org/10.15585/mmwr.mm7032e4 Export RIS Citation Information.

:

Rosenblum, Hannah G. ;

Hadler, Stephen C.

8 13 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for Pfizer-BioNTech and Moderna Covid-19 Vaccines,...
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021

CITE Title : Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021 Personal Author(s) : Rosenblum, Hannah G.;Hadler, Stephen C.;Moulia, Danielle;Shimabukuro, Tom T.;Su, John R.;Tepper, Naomi K.;Ess, Kevin C.;Woo, Emily Jane;Mba-Jonas, Adamma;Alimchandani, Meghna;Nair, Narayan;Klein, Nicola P.;Hanson, Kayla E.;Markowitz, Lauri E.;Wharton, Melinda;McNally, Veronica V.;Romero, José R.;Talbot, H. Keipp;Lee, Grace M.;Daley, Matthew F.;Mbaeyi, Sarah A.;Oliver, Sara E.; Corporate Authors(s) : United States. Advisory Committee on Immunization Practices.;CDC COVID-19 Response Team.;Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service.;Vanderbilt University School of Medicine.;United States. Food and Drug Administration.;Kaiser Permanente Northern California. Division of Research.;Marshfield Clinic Research Institute.;Franny Strong Foundation (West Bloomfield, Michigan);Arkansas. Department of Arkansas. Department of Health.;Stanford University School of Medicine.;Kaiser Permanente Colorado. Institute for Health Research.; Published Date : August 10, 2021 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/108729 Rosenblum, Hannah G. et al. (2021). Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021. 70 Rosenblum, Hannah G. et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021" 70 (2021) Rosenblum, Hannah G. et al. "Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and MRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update From the Advisory Committee on Immunization Practices — United States, July 2021" vol. 70, 2021 Export RIS Citation Information.

:

Rosenblum, Hannah G. ;

Hadler, Stephen C.

August 10, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Rare serious adverse events have been reported after COVID-19 vaccination, including Guillain-Barré syndrome ...